Titan Medical Inc (TMDI) Quote

"Bloom Burton Securities Inc. acted as sole and exclusive agent for the Offering."
Right out of the Titan playbook!
DILUTION, DILUTION, DILUTION!!

https://www.globenewswire.com/news-release/2025/04/23/3066428/0/en/Conavi-Medical-Corp-Announces-Closing-of-20M-Public-Offering.html
Has anyone finally covered? Hard to believe there is an investor or the volumes to cover 32/50 million shares.

Thank you for sharing.

Technology was scoopable we all though that, management lied, sold us out and mismanaged period!

Nice find. You should buy shares now while they’re still cheap. Scoooop those shares.

https://www.linkedin.com/posts/stevegbell_surgicalrobotics-roboticsurgery-singleport-ugcPost-7300480903288426498-yoEX?utm_source=share&utm_medium=member_ios&rcm=ACoAABZO5dQBEIQKK7jkejvP-4uxaZGl2_Y2sF4

What do you mean by ‘ours’?

I think 2025 is going to be our year!

Hi Geo. I hope you're doing well.
I havent been on this site since the ending fall out w titan. I guess our old board is gone. Nothing like sensorship and silencing their investors.. sickening. I'm really only able to reply because of an old message from you that was in my inbox here. I was just wondering if you guys are still posting anywhere about titan or whatever the loser name is now? Or, anything new.. lawsuits to join..? If you're interested, feel free to email me direct at magnetics101@yahoo.com . Thanks and take care.

Déjà vu… Dilute dilute dilute

BelizeMe

déjà-vu…. Also, the last time you talked about it here, it was around $15, right?

RBOT did a 1-30 RS last year which landed the stock at around $5/share
HOWEVER unlike POS Titan RBOT has steadily climbed from there to now approaching $20/ share!

I'm waiting for Giovinazzo and Steiner to be of some use!
But I don't have much hope

What are we looking at here buddy? Thanks in advance for any information.

It’s a shame most of us got totally whipped out. Oh well. Win some. Loose some.

cruel! but who knows who is joking?

this too! DATE FILED 2024-04-10
Why do it?
What a steal!

what a steal!

CNVI

What’s the new ticker ?

SUUUUUUUUUUUUUUem!

In other single port robotic news RBOT did a 1 for 30 RS a number of months ago….
The RS brought it to around $5 however unlike TMDI the stock stayed stable and has continued to rise to over $8 today.

Worth watching IMO

1 for 25 reverse split

TMDIF: effective Oct. 16,2024: Titan Medical has completed an amalgamation involving Conavi Medical Inc. Titan Medical and a wholly-owned subsidiary of the Company, 1000824255 Ontario Inc., which resulted in the reverse takeover of the Company by Conavi. Following completion of the Amalgamation, the Company has been renamed Conavi Medical Corp. Immediately prior to the closing of the Amalgamation, the Shares of the Company were consolidated on a 1-for-25 basis.

https://otce.finra.org/otce/dailyList?viewType=Deletions

RECOUNT RECOUNT

I think voting was done on Dominion machines.

Will do brutha! I lost on Verb too. Cuin2 is/was the biggest f’n hack pumper!



F him and his Blue Ocean Strategy!

News out!!!!

https://ir.titanmedicalinc.com/news-events/press-releases/detail/423/titan-announces-resignations-of-directors

"everything must change so that everything stays the same"

At least the directors got fired…..

Once again Titan shareholders give management what they want….

Never worked a single time before….

Congratulations on locking in your losses people….

https://ir.titanmedicalinc.com/news-events/press-releases/detail/422/titan-reports-voting-results-from-2023-annual-general-and

Thanks for your message Geo! I also got burned on VERB.. Please try to reach out to me again if you hear anything new. I've never been to stock twits but, maybe I should.. I thought that was where all the smart titan investors went. To Scoopsville...

Mag, we may go after’em. If you have an account on StockTwits, go read through some of our latest posts. A few of us are trying to rally the troops. This is what gives us a glimmer of hope…

https://www.reuters.com/legal/judge-rules-that-jj-owes-auris-1-bln-related-2019-robot-deal-2024-09-04/

I can't believe the same folks are still hanging in to titan. If you haven't sold out... It's over... Time to move on to another company. Check out Monogram robotics. Ortho robotics is where the market is heading...

Agree with you. Worst financial mistake of a lifetime. I regret hearing about this company and will never invest in a penny again.

Checking in probably one last time here as I've lost over 150k on this.. worst experience of my life.. even more painful that it went on for 12 plus years of pain. I'm writing here one last time hoping that no one is voting yes on this.. and if you do you might as well vote for Kamala as well. After losing 150k + and still having all those shares that have been reverse split who knows how many times I'm left with a total of just 1,500 or so in stock.. a yes vote will bring even less. Only one getting paid will be the company directors on both side and lawyers.. please vote no and shut these scammers down! And I won't be attending the conference call because there's nothing to hear. It's been fun communicating with some of you over the years here. Big lesson learned here. And that this place is full of evil people trying to scam all day everyday

what a steal!
https://titanmedicalinc.com/enos/
https://titanmedicalinc.com/videos/
https://titanmedicalinc.com/technology/
https://titanmedicalinc.com/wp-content/uploads/2022/10/Titan-Medical-White-Paper-Supporting-Single-Access-RAS-FINAL.pdf 🤮
simply thieves!

Can you please explain why you are recommending a no vote? I don’t think this company as it stands will be able to continue if they don’t do something. but in all honesty I haven’t read the circular yet so I don’t really have an educated opinion as of today. But I appreciate any info you are willing to provide. Thanks in advance and good luck. We may need it. Lol.

Withhold!!!

VOTE NO!!!!

https://ir.titanmedicalinc.com/news-events/press-releases/detail/414/titan-announces-filing-of-the-management-information

What’s going on with the voting ?

https://www.medicaldevice-network.com/data-insights/titan-medical-gets-grant-for-method-for-ergonomic-positioning-of-robotic-surgery-input-device/

No R&D……where did all those MILLIONS go since 12/31/23?????

VOTE NO!!!!!!!!

Titan Medical Reports Operating and Financial Results for the Second Quarter 2024
Titan Medical Inc.
Thu, Aug 15, 2024, 11:32 AM CDT6 min read\

TORONTO, Ontario, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), today reported financial results for the three and six months ended June 30, 2024.

Recent Activities in Q2 2024:

On May 29, 2024, the Company announced an amendment to the timeframe under which certain closing conditions must be met in the amalgamation agreement dated March 17, 2024 with Conavi Medical Inc. (“Conavi”), 1000824255 Ontario Inc. (a wholly-owned subsidiary of Titan) (the “Amalgamation Agreement”).

On July 5, 2024, the Company announced the second amendment to the timeframe under which certain conditions must be met in the Amalgamation Agreement and announced the Company was seeking an additional extension with the Toronto Stock Exchange (“TSX”) to hold its Annual General and Special Meeting of Shareholders (the “Titan AGM”) on or before September 30, 2024.

On August 14, 2024, the Company announced the third amendment to alter certain closing conditions that must be met in the Amalgamation Agreement.

extending the Outside Date (as such term is defined in the Amalgamation Agreement) for completion of the Proposed Transaction to October 10, 2024;

extending the date by which the Concurrent Financing (as such term is defined in the Amalgamation Agreement) must be committed to September 3, 2024;

reducing the minimum aggregate size of the Concurrent Financing (as such term is defined in the Amalgamation Agreement) from $15 million to $7.5 million;

extending the date by which Conavi financial statements must be completed to August 23, 2024;

reducing the minimum net cash Titan must have at the Effective Time (as such term is defined in this Amalgamation Agreement) from US$5 million to US$2 million;

extending the targeted date by which the information circular for the Titan AGM must be mailed to shareholders to September 3, 2024;

extending the targeted date by which the Titan AGM must be held to September 30, 2024;

extending the targeted date by which the information circular for the Conavi annual general meeting must be mailed to shareholders to September 3, 2024; and

extending the targeted date by which the Conavi annual general meeting must be held to September 30, 2024.

Financial Highlights:

As of June 30, 2024, Titan had cash of $3.9 million, compared to $7.5 million as at December 31, 2023. Working capital was $3.3 million as of June 30, 2024, compared to $5.5 million as at December 31, 2023.

Research and development (“R&D”) expenses were nil for the three months ended June 30, 2024 compared to $0.4 million for the three months ended June 30, 2023. R&D expenses were recovery of $0.1 million for the six months ended June 30, 2024 compared to $0.8 million for the six months ended June 30, 2023.

In the three and six months ended June 30, 2023, the Company implemented cost-cutting measures that significantly reduced R&D expenses. In the six months ended June 30, 2024, R&D expense recovery of $0.1 million is attributed to cancellation of stock options and restricted share units related to R&D personnel.

General and administrative (“G&A”) expenses were $1.1 million and $2.0 million for the three and six months ended June 30, 2024 compared to $4.3 million and $6.6 million for the comparative periods ended June 30, 2023. The decrease in G&A expenses in the current period is related to the cost-cutting measures implemented in Q2, 2023. In 2023, G&A expenses included severance charges of $1.4M, transaction costs of $1.5M, and increased stock-based compensation, offset by reduction in costs due to cost-cutting measures.

The Company’s interim consolidated financial statements and management discussions and analysis for the period ended June 30, 2024 are available at www.sedarplus.ca. The Company’s condensed interim consolidated financial statements have been prepared by management and reviewed by the Company’s auditors.

About Titan Medical

Titan Medical Inc. (TSX: TMD; OTC: TMDIF) is a medical technology company incorporated under the Business Corporations Act (Ontario) and headquartered in Toronto, Ontario, has developed an expansive patent portfolio related to the enhancement of robotic assisted surgery (RAS), including through a single access point, and is currently focused on evaluating new opportunities to further develop and license its intellectual property while pursuing the completion of its agreed upon Transaction with Conavi Medical Inc.

Cautionary Statement Regarding Forward-Looking Information

This news release contains “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws, which reflect the current expectations of management of Titan’s future growth, results of operations, performance and business prospects and opportunities. Forward-looking statements are frequently, but not always, identified by words such as “may”, “would”, “could”, “will”, “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate”, “potential for” and similar expressions, although these words may not be present in all forward-looking statements. Forward-looking statements that appear in this release may include, without limitation, references to: Titan evaluating new opportunities to further develop and license its intellectual property, the payment of future settlement amounts, the delivery of materials to Titan, and the completion of the merger with Conavi.

These forward-looking statements reflect management’s current beliefs with respect to future events, and are based on information currently available to management that, while considered reasonable by management as of the date on which the statements are made, are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in actions, events, conditions, results, performance or achievements to be materially different from those projected in the forward-looking statements. Forward-looking statements involve significant risks, uncertainties and assumptions and many factors could cause Titan’s actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements. Such factors and assumptions include, but are not limited to, Titan’s ability to retain key personnel; its ability to execute on its business plans and strategies; its ability to continue to license some or all its intellectual property to third parties and receive any material consideration and other factors listed in the “Risk Factors” section of Titan’s Annual Information Form for the fiscal year ended December 31, 2023 (which may be viewed at www.sedarplus.com). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results, performance, or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements.

Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions and Titan has attempted to identify important factors that could cause actual actions, events, conditions, results, performance or achievements to differ materially from those described in forward-looking statements, Titan cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. Except as required by law, Titan expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. Accordingly, investors should not place undue reliance on forward-looking statements. All the forward-looking statements are expressly qualified by the foregoing cautionary statements.

Contact
Chien Huang
Chief Financial Officer
investors@titanmedicalinc.com